Pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma
Definition
An infiltrating adenocarcinoma that arises from the epithelial cells of the pancreas. It affects males more often than females and the patients are usually over 50 years of age. Microscopically it is characterized by the presence of glandular (ductal) differentiation and desmoplastic stroma formation. Signs and symptoms include pain, loss of weight, and jaundice. It grows rapidly and is usually detected after it has metastasized to other anatomic sites. The prognosis is usually poor.
Also known as ductal adenocarcinoma of pancreas, ductal adenocarcinoma of the pancreas, pancreas ductal adenocarcinoma, pancreas tubular adenocarcinoma, pancreatic duct adenocarcinoma, pancreatic ductal adenocarcinoma, pancreatic ductal carcinoma, pancreatic tubular adenocarcinoma — per MONDO
Also identified as
- DOID 3498 per MONDO
- DOID 3587 per MONDO
- ICD9 157.3 per MONDO
- MESH D021441 per MONDO
- NCIT C9120 per MONDO
- UMLS C1335302 per MONDO
Affected Organs
| Organ | Involvement | Source |
|---|---|---|
| Alimentary part of gastrointestinal system | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
| Alimentary part of gastrointestinal system | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
| Exocrine pancreas | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
| Pancreas | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
| Pancreas | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
| Ventral pancreatic duct | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
Drugs indicated
| Drug | Relation | Source |
|---|---|---|
| Gemcitabine | may treat | MEDRT · Public domain (U.S. Government work) |